Lombard Odier Asset Management (USA)’s Advanced Micro Devices AMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300,000
Closed -$44.2M 347
2023
Q4
$44.2M Buy
300,000
+150,000
+100% +$17.7M 0.8% 34
2023
Q3
$15.4M Sell
150,000
-200,000
-57% -$21.7M 0.35% 82
2023
Q2
$39.9M Buy
350,000
+50,000
+17% +$5.2M 0.85% 29
2023
Q1
$29.4M Sell
300,000
-150,000
-33% -$12.2M 0.65% 34
2022
Q4
$29.1M Sell
450,000
-200,000
-31% -$13.2M 0.75% 33
2022
Q3
$41.2M Buy
650,000
+249,800
+62% +$21.3M 1.2% 18
2022
Q2
$30.6M Buy
400,200
+200,200
+100% +$18.7M 1.18% 20
2022
Q1
$21.9M Buy
+200,000
New +$23.9M 0.8% 31
2021
Q4
Sell
-85,000
Closed -$8.75M 358
2021
Q3
$8.75M Buy
+85,000
New +$8.69M 0.38% 48
2021
Q2
Sell
-75,000
Closed -$5.89M 289
2021
Q1
$5.89M Buy
+75,000
New +$6.46M 0.22% 62
2017
Q2
Sell
-2,500
Closed -$3.64M 248
2017
Q1
$3.64M Buy
+2,500
New +$31.7K 0.34% 87

Other funds holding AMD

Lombard Odier Asset Management (USA)'s AMD Position: Q1 2026 in Review

Lombard Odier Asset Management (USA) sold out of Advanced Micro Devices (AMD) in Q1 2026, closing a stake of 4,484 shares — an estimated $960K sold.

Lombard Odier Asset Management (USA) first reported a position in AMD in Q4 2015 and held it in 17 quarters. The position peaked at $23.4M in Q2 2022. 3,179 funds tracked by Wall St. Rank hold AMD as of Q1 2026.

  • Lombard Odier Asset Management (USA) reported no remaining Advanced Micro Devices position as of Q1 2026 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 4,484 Advanced Micro Devices shares in Q1 2026, an estimated $960K.
  • Lombard Odier Asset Management (USA) first reported a position in Advanced Micro Devices in Q4 2015 and held it in 17 quarters.
  • Lombard Odier Asset Management (USA)'s Advanced Micro Devices position peaked at $23.4M in Q2 2022.
  • 3,179 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q1 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2026, filed 15 May 2026.